MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on September 22, 2008; DOI: 10.1124/mol.108.050534


0026-895X/09/7501-113-123$20.00
Mol Pharmacol 75:113-123, 2009

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Erratum
Right arrow All Versions of this Article:
mol.108.050534v1
mol.108.050534v2
75/1/113    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lan, H.
Right arrow Articles by Neve, K. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lan, H.
Right arrow Articles by Neve, K. A.

A Dopamine D2 Receptor Mutant Capable of G Protein-Mediated Signaling but Deficient in Arrestin Binding

Hongxiang Lan, Yong Liu, Michal I. Bell, Vsevolod V. Gurevich, and Kim A. Neve

Departments of Behavioral Neuroscience (Y.L., M.I.B., K.A.N.) and Physiology & Pharmacology (H.L.), Oregon Health & Science University, and Veterans Affairs Medical Center (K.A.N.), Portland, Oregon; and Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee (V.V.G.)

Arrestins mediate G protein-coupled receptor desensitization, internalization, and signaling. Dopamine D2 and D3 receptors have similar structures but distinct characteristics of interaction with arrestins. The goals of this study were to compare arrestin-binding determinants in D2 and D3 receptors other than phosphorylation sites and to create a D2 receptor that is deficient in arrestin binding. We first assessed the ability of purified arrestins to bind to glutathione transferase (GST) fusion proteins containing the receptor third intracellular loops (IC3). Arrestin3 bound to IC3 of both D2 and D3 receptors, with the affinity and localization of the binding site indistinguishable between the receptor subtypes. Mutagenesis of the GST-IC3 fusion proteins identified an important determinant of the binding of arrestin3 in the N-terminal region of IC3. Alanine mutations of this determinant (IYIV212-215) in the full-length D2 receptor generated a signaling-biased receptor with intact ligand binding and G-protein coupling and activation, but deficient in receptor-mediated arrestin3 translocation to the membrane, agonist-induced receptor internalization, and agonist-induced desensitization in human embryonic kidney 293 cells. This mutation also decreased arrestin-dependent activation of extracellular signal-regulated kinases. The finding that nonphosphorylated D2-IC3 and D3-IC3 have similar affinity for arrestin is consistent with previous suggestions that the differential effects of D2 and D3 receptor activation on membrane translocation of arrestin and receptor internalization are due, at least in part, to differential phosphorylation of the receptors. In addition, these results imply that the sequence IYIV212-215 at the N terminus of IC3 of the D2 receptor is a key element of the arrestin binding site.


Received July 11, 2008; accepted September 19, 2008

Address correspondence to: Dr. Kim A. Neve, Portland VA Medical Center (R&D-30), 3710 SW US Veterans Hospital Road, Portland, OR 97239-2999. E-mail: nevek{at}ohsu.edu




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
Y. Namkung, C. Dipace, J. A. Javitch, and D. R. Sibley
G Protein-coupled Receptor Kinase-mediated Phosphorylation Regulates Post-endocytic Trafficking of the D2 Dopamine Receptor
J. Biol. Chem., May 29, 2009; 284(22): 15038 - 15051.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2009 by the American Society for Pharmacology and Experimental Therapeutics